Determinants of successful immune tolerance induction in hemophilia A: systematic review and meta-analysis

BACKGROUND: Immune tolerance induction (ITI) aims to eradicate anti-factor VIII (FVIII) antibodies (inhibitors) in persons with hemophilia A. However, this burdensome treatment fails in 10% to 40%. To estimate the chance of ITI success in clinical decision making, it is important to identify the pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Oomen, Ilja, Camelo, Ricardo M., Rezende, Suely Meireles, Voorberg, Jan, Mancuso, Maria Elisa, Oldenburg, Johannes, Carcao, Manuel, Matino, Davide, Lillicrap, David, Fischer, Kathelijn, Fijnvandraat, Karin, Gouw, Samantha C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986104/
https://www.ncbi.nlm.nih.gov/pubmed/36891524
http://dx.doi.org/10.1016/j.rpth.2022.100020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986104/
https://www.ncbi.nlm.nih.gov/pubmed/36891524
http://dx.doi.org/10.1016/j.rpth.2022.100020

Ejemplares similares